Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVATE Prophylaxis in Hemophilia A
NCT02282410Unknown
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Dec 2014
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Open-label, single-arm trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Annual Bleed Rate at 1 year. Status: unknown.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT02282410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282410.